PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan; knishi@college.fdcnet.ac.jp.\', \'Nishi Otolaryngology Clinic, Fukuoka, Japan.\', \'Section of Pathology, Department of Morphological Biology, Division of Biomedical Sciences, Fukuoka Dental College, Fukuoka, Japan.\', \'Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.\', \'Research Center for Regenerative Medicine, Fukuoka Dental College, Fukuoka, Japan.\', \'Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.\', \'Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.21873/invivo.12712
?:hasPublicationType
?:journal
  • In vivo (Athens, Greece)
is ?:pmid of
?:pmid
?:pmid
  • 34972736
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.
?:type

Metadata

Anon_0  
expand all